All Outputs (4)

Designing Prosocial More-Than-Human Rhetoric within Experiential Futures (2024)
Presentation / Conference Contribution
Coulton, P., Stead, M., Pilling, M., Crabtree, A., Chamberlain, A., & Sailaja, N. (2024, October). Designing Prosocial More-Than-Human Rhetoric within Experiential Futures. Presented at Mindtrek 2024, Tampere, Finland

While prosocial behaviour is often described as behaviour intended to help and benefit others, it is primarily considered through an anthropocentric lens in that the others in question are principally humans. In this research, we consider designed sy... Read More about Designing Prosocial More-Than-Human Rhetoric within Experiential Futures.

Responsibility and Regulation: Exploring Social Measures of Trust in Medical AI (2024)
Presentation / Conference Contribution
McGarry, G., Crabtree, A., Chamberlain, A., & Urquhart, L. D. (2024, September). Responsibility and Regulation: Exploring Social Measures of Trust in Medical AI. Presented at Second International Symposium on Trustworthy Autonomous Systems (TAS ’24), Austin, Texas, USA

This paper explores expert accounts of autonomous systems (AS) development in the medical device domain (MD) involving applications of artificial intelligence (AI), machine learning (ML), and other algorithmic and mathematical modelling techniques. W... Read More about Responsibility and Regulation: Exploring Social Measures of Trust in Medical AI.

AI and the iterable epistopics of risk (2024)
Journal Article
Crabtree, A., McGarry, G., & Urquhart, L. (2024). AI and the iterable epistopics of risk. AI & Society, https://doi.org/10.1007/s00146-024-02021-y

The risks AI presents to society are broadly understood to be manageable through ‘general calculus’, i.e., general frameworks designed to enable those involved in the development of AI to apprehend and manage risk, such as AI impact assessments, ethi... Read More about AI and the iterable epistopics of risk.

Sodium-glucose cotransporter-2 inhibitors (SGLT2) in frail or older people with type 2 diabetes and heart failure: a systematic review and meta-analysis (2024)
Journal Article
Aldafas, R., Crabtree, T., Alkharaiji, M., Vinogradova, Y., & Idris, I. (2024). Sodium-glucose cotransporter-2 inhibitors (SGLT2) in frail or older people with type 2 diabetes and heart failure: a systematic review and meta-analysis. Age and Ageing, 53(1), Article afad254. https://doi.org/10.1093/ageing/afad254

Objective: Sodium-glucose cotransporter-2 inhibitors (SGLT2Is) reduce cardio-metabolic and renal outcomes in patients with type 2 diabetes (T2D) but their efficacy and safety in older or frail individuals remains unclear. Methods: We searched PubMed,... Read More about Sodium-glucose cotransporter-2 inhibitors (SGLT2) in frail or older people with type 2 diabetes and heart failure: a systematic review and meta-analysis.